Showing results (121-130 of 275) with videos related to

Sort By:
Pageof 28
Nature Medicine|January 8, 2025
T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2023
Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED StudyThomas Carlier, Gauthier Frécon, Diana Mateus, et al.
Annals of Hematology|October 7, 2021
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA studyAlexandra-Cristina Paunescu, Christiane Bergman Copie, Sandra Malak, et al.
Haematologica|February 17, 2022
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphomaLouise Bouard, Benoit Tessoulin, Catherine Thieblemont, et al.
Annals of Hematology|July 1, 2020
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSABenoît Tessoulin, Kamal Bouabdallah, Barbara Burroni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2014
Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adultsPierre Peterlin, Jacques Delaunay, Thierry Guillaume, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid LymphomasWendy Revailler, Anne Ségolène Cottereau, Cedric Rossi, et al.
BMC Cancer|August 30, 2019
The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myelomaLina Benaniba, Benoit Tessoulin, Sabrina Trudel, et al.
Neuroscience Applied|July 14, 2025
Colour vision defects in schizophrenia spectrum disorders: A systematic reviewArnav Gupta, Jason Tran, Nicholas Fabiano, et al.
Cancer|October 7, 2014
Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: results of a multicenter prospective phase 2 trialMohamad Mohty, Florent Malard, Didier Blaise, et al.
Pageof 28